Lymphoblastic Leukemia, Acute, Childhood Active Not Recruiting Phase Trials for Tocilizumab (DB06273)

IndicationStatusPhase
DBCOND0044925 (Lymphoblastic Leukemia, Acute, Childhood)Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02906371Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release SyndromeTreatment